Dr Peter Beyer is a public health expert who joined GARDP from the World Health Organization (WHO) where he led the Unit responsible for developing global initiatives to foster the development of and access to new antimicrobial treatments. Peter was instrumental in setting up GARDP as well as the AMR Action Fund. Previously, he was responsible for WHO’s work on intellectual property and access to medicines, setting up the trilateral collaboration among the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO) and WHO as well as providing technical assistance to countries to facilitate access to affordable HIV and hepatitis treatments in particular. He is the chair of the Expert Advisory Group of the Medicines Patent Pool that assesses the terms of conditions of all proposed licence agreements. Peter has extensive experience in international negotiations. As a Legal Advisor to the Swiss Federal Institute of Intellectual Property in Berne, he negotiated bilateral free trade agreements and was responsible for the bilateral dialogue between Switzerland and China on intellectual property. During his time with the Ecologic Institute in Berlin he was an adviser to the German Ministry of the Environment in international treaty negotiations and drafted the German law on CO2 emissions trading. Peter is a trained lawyer and was admitted to bar in Berlin in 2002. He holds a PhD from the University of Freiburg, Germany on European environmental law.
